• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Sultiame

CAS No. 61-56-3

Sultiame ( —— )

产品货号. M26833 CAS No. 61-56-3

Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1085 有现货
10MG ¥1555 有现货
25MG ¥2730 有现货
50MG ¥4293 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Sultiame
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.
  • 产品描述
    Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.(In Vitro):Sultiame promotes a modest intracellular acidosis in central neurons via acting as a carbonic anhydrase inhibitor, thereby reducing the frequency of action potentials and epileptiform bursts.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    M1 mAChR
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    61-56-3
  • 分子量
    290.4
  • 分子式
    C10H14N2O4S2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    NS(=O)(=O)c1ccc(cc1)N1CCCCS1(=O)=O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Lv X, et al. M(1) muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons. Neuropharmacology. 2017 May 15;118:209-222.
产品手册
关联产品
  • Demethoxydeacetoxyps...

    Demethoxydeacetoxypseudolaric acid B's the metabolic reaction of TDA in vivo is mainly occurred in blood and contributes to be the hydrolysis of plasma esterase to ester bond, as well as the glucosylation reaction.

  • GLP-1 moiety from Du...

    GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist.

  • Picrasidine I

    Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.